IconicAlpha
← Back to the wall
Johnson & Johnson

Johnson & Johnson

JNJ · Healthcare · Pharmaceuticals

Market cap
$642.79B
Price
$266.16
Daily change
-0.21%
Rank
#17

Updated 25 min ago · data delayed ≥15 min

Iconic Score

Proprietary
74/ 100
Scale76
Momentum49
Sector leadership98

Ranked #15 of 503 by Iconic Score · #2 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a blend of scale, market attention, and category leadership.

Iconic Profile

Johnson & Johnson (JNJ) is a leading global healthcare company with a market capitalization of $618.6 billion, primarily operating in the Pharmaceuticals sector. The company develops a wide range of products, including prescription medications, medical devices, and consumer health goods, with a strong emphasis on innovation and research. JNJ holds a prominent position in the market, benefiting from a diverse portfolio that addresses various health needs, including immunology, oncology, and infectious diseases. Its extensive distribution network and established brand reputation contribute to its competitive advantage. Johnson & Johnson's commitment to improving health outcomes and its ongoing investment in research and development underscore its significance in the healthcare landscape, making it a key player in addressing global health challenges.

Visit website ↗Compare ⇄Claim this profile

Enterprise tier: claim your logo to manage how your brand is represented.